Artemis Investment Management LLP
Position in BMY — Bristol Myers Squibb Co
CIK 1535385
EDINBURGH, X0
Position in BMY
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$174,993,323
+$81,097,107 QoQ
Shares Held
2,885,298
+65.7% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
1.86%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Artemis Investment Management LLP holds $1,107,485,466 across 8 Drug Manufacturers - General names. BMY ranks #4 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,444,565 | $284,897,109 | |
| 2 | ABBV |
AbbVie Inc.
|
1,041,483 | $226,512,137 | |
| 3 | PFE |
Pfizer Inc
|
7,392,508 | $207,581,624 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
2,885,298 | $174,993,323 | |
| 5 | BIIB |
Biogen Inc.
|
571,571 | $104,786,111 | |
| 6 | LLY |
ELI LILLY & Co
|
92,854 | $85,404,323 | |
| 7 | JNJ |
Johnson & Johnson
|
65,168 | $15,929,665 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
52,961 | $7,381,174 |
All Filings in BMY
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $174,993,323 | 2,885,298 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $93,896,216 | 1,740,753 | Shares | Sole | 2026-02-02 | |
| 2025-03-31 | $14,767,569 | 242,131 | Shares | Sole | 2025-04-24 | |
| 2023-06-30 | $2,589,079 | 40,486 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $106,204,267 | 1,532,308 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $135,520,703 | 1,883,540 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $142,106,137 | 1,998,961 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $150,721,340 | 1,957,420 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $145,066,718 | 1,986,399 | Shares | Sole | 2022-04-21 | |
| 2021-09-30 | $11,551,404 | 195,224 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $8,754,088 | 131,010 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $56,148,579 | 889,412 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $62,059,898 | 1,000,482 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $62,733,975 | 1,040,537 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $71,564,421 | 1,217,082 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $101,105,002 | 1,813,868 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||